Over-the-counter use of short-acting beta-2 agonists: a systematic review

References

• O’Byrne PM, Jenkins C, Bateman EDThe paradoxes of asthma management: time for a new approach?Eur Respir J2017501701103 10.1183/13993003.01103-2017 28889114
   PubMed Web of Science ®Google Scholar
• O’Byrne PM, Reddel HK, Beasley RThe management of mild asthmaEur Respir J2021 10.1183/13993003.03051-2020 33446611
   PubMedGoogle Scholar
• Eisner MD, Lieu TA, Chi F, Capra AM, Mendoza GR, Selby JV, et al.Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthmaEur Respir J2001 10.1183/09031936.01.17202330 11334125
   PubMed Web of Science ®Google Scholar
• Romão M, Godinho AR, Teixeira PM, Mendes Z, Bernardo F, Rodrigues AT, et al.Characteristics of reliever inhaler users and asthma control: a cross-sectional multicenter study in Portuguese community pharmaciesJ Asthma Allergy2021 10.2147/JAA.S315678 34354362 8331120
   PubMed Web of Science ®Google Scholar
• Thomson NCReliever Inhaler Overuse, Asthma Symptoms, and DepressionJ Allergy Clin Immunol2015 10.1016/j.jaip.2015.07.002
   Web of Science ®Google Scholar
• Bloom CI, Cabrera C, Arnetorp S, Coulton K, Nan C, van der Valk RJP, et al.Asthma-related health outcomes associated with short-acting β2-agonist inhaler use: an observational UK study as part of the SABINA global programAdv Ther20203741904208 1:CAS:528:DC%2BB3cXhsVKktLzJ 10.1007/s12325-020-01444-5 32720299
   PubMed Web of Science ®Google Scholar
• Gerald JK, Carr TF, Wei CY, Holbrook JT, Gerald LBAlbuterol overuse: a marker of psychological distress?J Allergy Clin Immunol Pract20153957962 10.1016/j.jaip.2015.06.021 26341049 4641773
   PubMed Web of Science ®Google Scholar
• Nwaru BI, Ekström M, Hasvold P, Wiklund F, Telg G, Janson COveruse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programmeEur Respir J2020 10.1183/13993003.01872-2019 32139461 7160635
   PubMedGoogle Scholar
• Di Marco F, D’Amato M, Lombardo FP, Micheletto C, Heiman F, Pegoraro V, et al.The burden of short-acting β2-agonist use in asthma: is there an Italian case? An update from SABINA programAdv Ther2021 10.1007/s12325-021-01772-0 34043208 8280008
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention, 2023. 2023.
   Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention (2022 Update) 2022. https://ginasthma.org/. Accessed 13 Feb 2023.
   Google Scholar
• Muneswarao J, Hassali MA, Ibrahim B, Saini B, Ali IAH, Verma AKIt is time to change the way we manage mild asthma: an update in GINA 2019Respir Res201920183 10.1186/s12931-019-1159-y 31412856 6694574
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention. 2019.
   Google Scholar
• Vong SK, Kang L, Carter SRConsumers’ self-reported adherence to directions for non-prescription medicines and the role of risk perceptionRes Soc Admin Pharm20221839293938 10.1016/j.sapharm.2022.06.004
   PubMed Web of Science ®Google Scholar
• Azzi EA, Kritikos V, Peters MJ, Price DB, Srour P, Cvetkovski B, et al.Understanding reliever overuse in patients purchasing over-the-counter short-acting beta 2 agonists: an Australian community pharmacy-based surveyBMJ Open2019 10.1136/bmjopen-2019-028995 31412998 6701672
   PubMed Web of Science ®Google Scholar
• Janson C, Menzies-Gow A, Nan C, Nuevo J, Papi A, Quint JK, et al.SABINA: an overview of short-acting β2-agonist use in asthma in European countriesAdv Ther2020 10.1007/s12325-020-01233-0 31981105 7089727
   PubMed Web of Science ®Google Scholar
• Loh ZC, Hussain R, Balan S, Saini B, Muneswarao J, Ong SC, et al.Perceptions, attitudes, and behaviors of asthma patients towards the use of short-acting β2-agonists: a systematic reviewPLoS ONE202318 10.1371/journal.pone.0283876 37079594 10118161
   PubMed Web of Science ®Google Scholar
• Tong V, Raynor DK, Aslani PUser testing as a method for identifying how consumers say they would act on information related to over-the-counter medicinesRes Soc Admin Pharm2017 10.1016/j.sapharm.2016.06.001
   Web of Science ®Google Scholar
• Reddel HKUpdated Australian guidelines for mild asthma: What’s changed and why?Aust Prescr2020 10.18773/austprescr.2020.076 33363311 7738702
   PubMed Web of Science ®Google Scholar
• Kaplan A, van Boven JFM, Ryan D, Tsiligianni I, Bosnic-Anticevich SGINA 2020: potential impacts, opportunities, and challenges for primary careJ Allergy Clin Immunol2021 10.1016/j.jaip.2020.12.035 33129885
   PubMed Web of Science ®Google Scholar
• Kaplan AG, Correia-de-Sousa J, McIvor AGlobal quality statements on reliever use in asthma in adults and children older than 5 years of ageAdv Ther2021 10.1007/s12325-021-01621-0 33586006 7882466
   PubMed Web of Science ®Google Scholar
• Gibson P, Henry D, Francis L, Cruickshank D, Dupen F, Higginbotham N, et al.Association between availability of non-prescription beta 2 agonist inhalers and undertreatment of asthmaBr Med J199330615141518 1:STN:280:DyaK3s3pvFaktw%3D%3D 10.1136/bmj.306.6891.1514
   PubMedGoogle Scholar
• Comino EJ, Henry RL, Mitchell CA, Bauman A, Monaco RAsthma management and mode of acquisition of inhaled bronchodilatorsAust N Z J Med1995 10.1111/j.1445-5994.1995.tb01494.x 8588771
   PubMedGoogle Scholar
• Cooper RSurveillance and uncertainty: Community pharmacy responses to over the counter medicine abuseHealth Soc Care Community2013 10.1111/hsc.12012 23320510
   PubMed Web of Science ®Google Scholar
• Zeitouni M, Al-Moamary MS, Coussa M, Riachy M, Mahboub B, Alhuraish F, et al.Challenges and recommendations for the management of asthma in the Middle East and AfricaAnn Thorac Med2022177180 10.4103/atm.atm_469_21 35651897 9150662
   PubMed Web of Science ®Google Scholar
• Parums DVEditorial: Review articles, systematic reviews, meta-analysis, and the updated preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2020 GuidelinesMed Sci Monit2021 10.12659/MSM.934475 34848673 8647456
   PubMed Web of Science ®Google Scholar
• O’Gorman CS, Macken AP, Cullen W, Saunders J, Dunne C, Higgins MFWhat are the differences between a literature search, a literature review, a systematic review and a meta-analysis? And why is a systematic review considered to be so good?Ir Med J2013106810 24273836
   PubMedGoogle Scholar
• Tober MPubMed, ScienceDirect, Scopus or Google Scholar – Which is the best search engine for an effective literature research in laser medicine?Medical Laser Appl201126139144 10.1016/j.mla.2011.05.006
   Google Scholar
• Rahmani N, Salehi A, Molavi Vardanjani H, Marzban M, Behbood AUsing STROBE checklist to assess the reporting quality of observational studies affiliated with Shiraz University of Medical Sciences, and its correlates: a scientometric study from IranScientometrics2020 10.1007/s11192-019-03317-3
   Web of Science ®Google Scholar
• Limaye D, Pitani RS, Limaye V, Sydymanov A, Otzipka C, Ziesenis P, et al.Development of a quantitative scoring method for STROBE checklistActa Pol Pharm2018 10.32383/appdr/84804
   Web of Science ®Google Scholar
• Eades CE, Ferguson JS, O’Carroll REPublic health in community pharmacy: a systematic review of pharmacist and consumer viewsBMC Public Health2011 10.1186/1471-2458-11-582 21777456 3146877
   PubMed Web of Science ®Google Scholar
• Dixon-Woods M, Agarwal S, Jones D, Young B, Sutton ASynthesising qualitative and quantitative evidence: a review of possible methodsJ Health Serv Res Policy2005 10.1258/1355819052801804 15667704
   PubMedGoogle Scholar
• Bearman M, Dawson PQualitative synthesis and systematic review in health professions educationMed Educ2013 10.1111/medu.12092 23398011
   PubMed Web of Science ®Google Scholar
• Seers KWhat is a qualitative synthesis?Evid Based Nurs2012 10.1136/ebnurs-2012-100977 23002176
   PubMedGoogle Scholar
• Alzaabi A, Al Busaidi N, Pradhan R, Shandy F, Ibrahim N, Ashtar M, et al.Over-prescription of short-acting β2-agonists and asthma management in the Gulf region: a multicountry observational studyAsthma Res Pract202283 10.1186/s40733-022-00085-5 35799290 9260980
   PubMedGoogle Scholar
• Azzi E, Kritikos V, Peters M, Price D, Cvetkovski B, Alphonse PS, et al.Perceptions, attitudes, and behaviors of short-acting beta2 agonist users: an Australian cross-sectional community pharmacy-based studyJ Asthma202259178188 1:CAS:528:DC%2BB3cXit1Ggtb%2FO 10.1080/02770903.2020.1841223 33086885
   PubMed Web of Science ®Google Scholar
• Bateman ED, Price DB, Wang H-C, Khattab A, Schonffeldt P, Catanzariti A, et al.Short-acting β 2 -agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III studyEur Respir J2021 10.1183/13993003.01402-2021 34667060
   PubMed Web of Science ®Google Scholar
• Yorgancıoğlu A, Aksu K, Naycı SA, Ediger D, Mungan D, Gül U, et al.Short-acting β2-agonist prescription patterns in patients with asthma in Turkey: results from SABINA IIIBMC Pulm Med202222216 1:CAS:528:DC%2BB38XhsVKhtrrM 10.1186/s12890-022-02008-9 35655251 9161536
   PubMed Web of Science ®Google Scholar
• Al-Jahdali H, Wali S, Albanna A, Al Harbi A, Allehebi R, Arwadi A, et al.Overprescription of short-acting β2 -agonists among patients with asthma in Saudi Arabia: results from the SABINA III cohort studyClin Respir J2022 10.1111/crj.13553 36279888 9716708
   PubMed Web of Science ®Google Scholar
• Douglass JA, Goeman DP, McCarthy EA, Sawyer SM, Aroni RA, Stewart K, et al.Over-the-counter β2-agonist purchase versus script: a cross-sectional studyRespir Med2012106223229 10.1016/j.rmed.2011.09.012 22040532
   PubMed Web of Science ®Google Scholar
• Bao W, Zhang Y, Hang J, Guo Y, Tang W, Yun C, et al.Short-acting beta-2 agonist prescription patterns and clinical outcomes in Chinese patients with asthma: an observational study in mainland China for the SABINA programmeTher Adv Respir Dis20221617534666221115054 1:CAS:528:DC%2BB38Xjt1Whs7nM 10.1177/17534666221115054 36065527 9449520
   PubMed Web of Science ®Google Scholar
• Montero-Arias F, Garcia JCH, Gallego MP, Antila MA, Schonffeldt P, Mattarucco WJ, et al.Over-prescription of short-acting β2-agonists is associated with poor asthma outcomes: results from the Latin American cohort of the SABINA III studyJ Asthma2022 10.1080/02770903.2022.2082305 35670783
   PubMed Web of Science ®Google Scholar
• Avdeev S, Voznesenskiy N, Boldina M, Ignatova G, Kostina N, Kulbaisov A, et al.SABA overuse in Russia—burden and possible causes: an analysis of the Russian population in the SABINA III (SABA use IN Asthma) studyJ Asthma Allergy2022 10.2147/JAA.S350393 35368426 8965337
   PubMed Web of Science ®Google Scholar
• Price D, Hancock K, Doan J, Taher SW, Muhwa CJ, Farouk H, et al.Short-acting β2-agonist prescription patterns for asthma management in the SABINA III primary care cohortNPJ Prim Care Respir Med20223237 10.1038/s41533-022-00295-7 36175556 9522811
   PubMed Web of Science ®Google Scholar
• Reddel HK, Ampon RD, Sawyer SM, Peters MJRisks associated with managing asthma without a preventer: urgent healthcare, poor asthma control and over-the-counter reliever use in a cross-sectional population surveyBMJ Open20177 10.1136/bmjopen-2017-016688 28947448 5623555
   PubMed Web of Science ®Google Scholar
• Campbell DA, Ruffin RE, Wilson DJD, Farmer EA, Wakefield MA, Chittleborough CROver-the-counter purchase of inhaled beta-2 agonists: a qualitative study of asthma patientsHealth Promot J Austr2000103842
   Google Scholar
• Shen S-Y, Chen C-W, Liu T-C, Wang C-Y, Chiu M-H, Chen Y-J, et al.SABA prescriptions and asthma management practices in patients treated by specialists in Taiwan: results from the SABINA III studyJ Formos Med Assoc202212125272537 10.1016/j.jfma.2022.05.014 35718640
   PubMed Web of Science ®Google Scholar
• Pedrozo-Pupo JC, Gallego MCP, de Álvarez IJB, Raad RAJ, Pinilla ACC, Londoño HR, et al.A cross-sectional study on prescription patterns of short-acting β2-agonists in patients with asthma: results from the SABINA III Colombia cohortJ Asthma Allergy20221511671178 10.2147/JAA.S365009 36051434 9427209
   PubMed Web of Science ®Google Scholar
• Modi M, Mody K, Jhawar P, Sharma L, Padukudru Anand M, Gowda G, et al.Short-acting β2-agonists over-prescription in patients with asthma: an Indian subset analysis of international SABINA III studyJ Asthma2022 10.1080/02770903.2022.2147079 36519934
   PubMed Web of Science ®Google Scholar
• Khattab A, Madkour A, Ambaram A, Smith C, Muhwa CJ, Mecha JO, et al.Over-prescription of short-acting β2-agonists is associated with poor asthma outcomes: results from the African cohort of the SABINA III studyCurr Med Res Opin2022 10.1080/03007995.2022.2100649 36031882
   PubMed Web of Science ®Google Scholar
• Gibbons DC, Aggarwal B, Fairburn-Beech J, Hinds D, Fletcher M, Bosnic-Anticevich S, et al.Treatment patterns among non-active users of maintenance asthma medication in the United Kingdom: a retrospective cohort study in the Clinical Practice Research DatalinkJ Asthma2021 10.1080/02770903.2020.1728767 32090642
   PubMed Web of Science ®Google Scholar
• Domingo C, Singh DThe changing asthma management landscape and need for appropriate SABA prescriptionAdv Ther2023 10.1007/s12325-022-02410-z 36715896 10070225
   PubMedGoogle Scholar
• Blakeston S, Harper G, Zabala MJIdentifying the drivers of patients’ reliance on short-acting β2-agonists in asthmaJ Asthma20215810941101 1:CAS:528:DC%2BB3cXhsVKmu7vK 10.1080/02770903.2020.1761382 32469667
   PubMed Web of Science ®Google Scholar
• Kaplan A, Mitchell PD, Cave AJ, Gagnon R, Foran V, Ellis AKEffective asthma management: is it time to let the AIR out of SABA?J Clin Med2020 10.3390/jcm9040921 33053826 7601151
   PubMed Web of Science ®Google Scholar
• Serhal S, Saini B, Bosnic-Anticevich S, Krass I, Emmerton L, Bereznicki B, et al.A targeted approach to improve asthma control using community pharmacistsFront Pharmacol2021 10.3389/fphar.2021.798263 35024035 8743269
   PubMedGoogle Scholar
• Australian Institute of Health and Welfare. About summary: chronic respiratory conditions. 2023.
   Google Scholar
• Tarraf H, Aydin O, Mungan D, Albader M, Mahboub B, Doble A, et al.Prevalence of asthma among the adult general population of five Middle Eastern countries: results of the SNAPSHOT programBMC Pulm Med2018 10.1186/s12890-018-0621-9 29751756 5948696
   PubMed Web of Science ®Google Scholar
• Ministry of Health R of K. Kenya asthma management guideline. n.d.
   Google Scholar
• Baard CB, Franckling-Smith Z, Munro J, Workman L, Zar HJAsthma in South African adolescents: a time trend and risk factor analysis over two decadesERJ Open Res2021 10.1183/23120541.00576-2020 33834055 8021807
   PubMedGoogle Scholar
• Alzaabi A, Idrees M, Behbehani N, Khaitov MR, Tunceli K, Urdaneta E, et al.Cross-sectional study on asthma insights and management in the gulf and RussiaAllergy Asthma Proc2018 10.2500/aap.2018.39.4180 30326990 6212633
   PubMed Web of Science ®Google Scholar
• Emelyanov AThe prevalence of asthma and allergic rhinitis among adults in St. Petersburg, Russia*1J Allergy Clin Immunol2004 10.1016/j.jaci.2004.01.657
   Google Scholar
• Lobuteva L, Lobuteva A, Zakharova O, Kartashova O, Kocheva NThe modern Russian pharmaceutical market: consumer attitudes towards distance retailing of medicinesBMC Health Serv Res202222582 10.1186/s12913-022-07991-7 35490211 9055368
   PubMed Web of Science ®Google Scholar
• Statista Research Department. Pharmaceutical e-commerce in Russia - statistics & facts 2022. https://www.statista.com/topics/7612/pharmaceutical-e-commerce-in-russia/#topicOverview. Accessed 18 Feb 2023.
   Google Scholar
• Glaser J, Rolita LEducating older adults in OTC medication use over-the-counter medicationGeriatr Aging200912103109
   Google Scholar
• Curry LC, Walker C, Hogstel MO, Burns PTeaching older adults to self-manage medications: preventing adverse drug reactionsJ Gerontol Nurs2005 10.3928/0098-9134-20050401-09 15839523
   PubMedGoogle Scholar
• Schifano F, Chiappini S, Miuli A, Mosca A, Santovito MC, Corkery JM, et al.Focus on over-the-counter drugs’ misuse: a systematic review on antihistamines, cough medicines, and decongestantsFront Psychiatry2021 10.3389/fpsyt.2021.657397 34025478 8138162
   PubMed Web of Science ®Google Scholar
• Al-babtain B, Cheema E, Hadi MAImpact of community-pharmacist-led medication review programmes on patient outcomes: a systematic review and meta-analysis of randomised controlled trialsRes Social Adm Pharm2022 10.1016/j.sapharm.2021.04.022 33965357
   PubMedGoogle Scholar
• Feldman WB, Avorn J, Kesselheim ASOver-the-counter availability of rescue inhalers for asthma—replyJAMA2022328216217 10.1001/jama.2022.8775 35819426
   PubMed Web of Science ®Google Scholar
• Pharmaceutical society of Australia. Professional practice standards, Version 5. 2017.
   Google Scholar
• Gray SE, Press VGOver-the-counter availability of rescue inhalers for asthmaJAMA2022328215216 10.1001/jama.2022.8772 35819429
   PubMedGoogle Scholar
• Saini B, Krass I, Smith L, Bosnic-Anticevich S, Armour CRole of community pharmacists in asthma—Australian research highlighting pathways for future primary care modelsAust Med J2011 10.4066/AMJ.2011.790
   Google Scholar
• Driesenaar JA, De Smet PAGM, van Hulten R, Hu L, van Dulmen SCommunication during counseling sessions about inhaled corticosteroids at the community pharmacyPatient Prefer Adherence20161022392254 10.2147/PPA.S108006 27843303 5098562
   PubMed Web of Science ®Google Scholar
• Bereznicki B, Peterson G, Jackson S, Walters EH, Gee PThe sustainability of a community pharmacy intervention to improve the quality use of asthma medicationJ Clin Pharm Ther2011 10.1111/j.1365-2710.2010.01165.x 22017213
   PubMed Web of Science ®Google Scholar
• Muth C, Blom JW, Smith SM, Johnell K, Gonzalez-Gonzalez AI, Nguyen TS, et al.Evidence supporting the best clinical management of patients with multimorbidity and polypharmacy: a systematic guideline review and expert consensusJ Intern Med2019 10.1111/joim.12842 30536464
   PubMed Web of Science ®Google Scholar
• Park HJ, Byun MK, Kim HJ, Ahn CM, Rhee CK, Kim K, et al.Regular follow-up visits reduce the risk for asthma exacerbation requiring admission in Korean adults with asthmaAllergy Asthma Clin Immunol2018 10.1186/s13223-018-0250-0 30002684 6038276
   PubMed Web of Science ®Google Scholar
• Sandelowsky H, Ställberg B, Wiklund F, Telg G, de Fine LS, Janson CAnnual and post-exacerbation follow-up of asthma patients in clinical practice—a large population-based study in SwedenJ Asthma Allergy202215475486 10.2147/JAA.S357086 35444428 9014309
   PubMed Web of Science ®Google Scholar
• Horne R, Price D, Cleland J, Costa R, Covey D, Gruffydd-Jones K, et al.Can asthma control be improved by understanding the patient’s perspective?BMC Pulm Med2007 10.1186/1471-2466-7-8 17518999 1894634
   PubMedGoogle Scholar
• Bandura A. Social cognitive theory of personality. Handbook of Personality, Vol. 2; 1999.
   Google Scholar
• Phipps M, Ozanne LK, Luchs MG, Subrahmanyan S, Kapitan S, Catlin JR, et al.Understanding the inherent complexity of sustainable consumption: A social cognitive frameworkJ Bus Res2013 10.1016/j.jbusres.2012.08.016
   Web of Science ®Google Scholar
• Taherdoost HA review of technology acceptance and adoption models and theoriesProcedia Manuf2018 10.1016/j.promfg.2018.03.137
   Google Scholar
• Carillo K. Understanding IS theory: an interpretation of key is theoretical frameworks using social cognitive theory, 2012. https://doi.org/10.1007/978-1-4419-9707-4_13.
   Google Scholar
• McLeod S. Albert Bandura’s social learning theory|simply psychology. Simply Psychol 2016.
   Google Scholar
• O’Dwyer S, Greene G, MacHale E, Cushen B, Sulaiman I, Boland F, et al.Personalized biofeedback on inhaler adherence and technique by community pharmacists: a cluster randomized clinical trialJ Allergy Clin Immunol2020 10.1016/j.jaip.2019.09.008
   Web of Science ®Google Scholar
• Basheti IA, Reddel HK, Armour CL, Bosnic-Anticevich SZImproved asthma outcomes with a simple inhaler technique intervention by community pharmacistsJ Allergy Clin Immunol2007 10.1016/j.jaci.2007.02.037 17433831
   PubMed Web of Science ®Google Scholar
• Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, et al.Global initiative for asthma strategy 2021 executive summary and rationale for key changesAm J Respir Crit Care Med2022 10.1164/rccm.202109-2205PP 35202561 9838630
   PubMed Web of Science ®Google Scholar